You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

13-244

Showing 26 - 50 of 4,684
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Atrial Fibrillation Trial in United States (Decision Aid)

Completed
Has Results
  • Atrial Fibrillation
  • Decision Aid
  • Birmingham, Alabama
  • +4 more
Dec 29, 2021

Ulcerative Colitis Trial in Ukraine, United States (NX-13 250mg IR, NX-13 500mg IR, NX-13 500mg MR)

Completed
  • Ulcerative Colitis
  • NX-13 250mg IR
  • +3 more
  • Huntsville, Alabama
  • +30 more
Jan 6, 2023

HIV Trial in United States (MN rgp120/HIV-1 and A244 rgp120/HIV-1, QS-21, rgp120/HIV-1MN)

Completed
  • HIV Infections
  • MN rgp120/HIV-1 and A244 rgp120/HIV-1
  • +2 more
  • Baltimore, Maryland
  • +3 more
Oct 28, 2021

Squamous Intraepithelial Lesions of the Cervix, Human Papilloma Virus Infection, Cervix Lesion Trial in Orléans (PAPILOCARE)

Recruiting
  • Squamous Intraepithelial Lesions of the Cervix
  • +2 more
  • PAPILOCARE
  • Orléans, France
    Centre Hospitalier Régional d'Orléans, France
Dec 27, 2022

Dental Implant Failed, Osseointegration Failure of Dental Implant Trial in Istanbul (Patients selection, Implnat placement,

Completed
  • Dental Implant Failed
  • Osseointegration Failure of Dental Implant
  • Patients selection
  • +2 more
  • Istanbul, Turkey
    Istanbul Medipol University, School of Dentistry
Oct 20, 2023

Prostate Adenocarcinoma, Prostate Cancer Trial in San Francisco (Hyperpolarized Carbon C 13 Pyruvate, Magnetic Resonance

Recruiting
  • Prostate Adenocarcinoma
  • Prostate Cancer
  • Hyperpolarized Carbon C 13 Pyruvate
  • +2 more
  • San Francisco, California
    University of California, San Francisco
Oct 3, 2022

Non-Alcoholic Fatty Liver Disease Trial in Zagazig (abdominal U/S, Fibroscan with Controlled Attenuated Parameter (CAP scan):)

Enrolling by invitation
  • Non-Alcoholic Fatty Liver Disease
  • abdominal U/S
  • Fibroscan with Controlled Attenuated Parameter (CAP scan):
  • Zagazig, Sharkia, Egypt
    Zagazig University
Oct 24, 2023

HIV, Hypertension Trial in Kampala (Integrated HIV/HTN care model)

Active, not recruiting
  • HIV
  • Hypertension
  • Integrated HIV/HTN care model
  • Kampala, Central Region, Uganda
    Infectious Diseases Research Collaboration
Nov 1, 2022

Gut Microbiome and Depression

Recruiting
  • Multiple Sclerosis
  • Depression
  • Neuro-QoL T-score determination
  • Saint Louis, Missouri
    Washington University in St Louis
Mar 29, 2023

Migraine Headache Trial in United States (DFN-15 Active, DFN-15 Placebo)

Completed
Has Results
  • Migraine Headache
  • DFN-15 Active
  • DFN-15 Placebo
  • Birmingham, Alabama
  • +44 more
Dec 15, 2022

Oral Cavity Cancer Trial in Mumbai, Navi Mumbai, Varanasi (Gross examination of the resection specimen, Frozen section)

Recruiting
  • Oral Cavity Cancer
  • Gross examination of the resection specimen
  • Frozen section
  • Mumbai, Maharashtra, India
  • +2 more
Apr 26, 2022

Cardiopulmonary Disease Trial in Jacksonville (TEE with SGA, TEE with Deep Sedation)

Not yet recruiting
  • Cardiopulmonary Disease
  • TEE with SGA
  • TEE with Deep Sedation
  • Jacksonville, Florida
    UF Health Jacksonville
Nov 28, 2022

Aging Trial (vaccine)

Not yet recruiting
  • Aging
  • vaccine
  • (no location specified)
Nov 8, 2023

Radiation Lung Injury Trial in Chengdu (Death mesenchymal stem cell)

Recruiting
  • Radiation Lung Injury
  • Death mesenchymal stem cell
  • Chengdu, Sichuan, China
    West China Hospital
Aug 31, 2023

Patients Diagnosed With NSAID Sensitivity in Thailand

Completed
  • Aspirin Sensitivity
  • +7 more
  • aspirin, NSAIDs, paracetamol
  • Bangkok, Thailand
    Faculty of Medicine, Chulalongkorn University
Feb 8, 2022

Postoperative Analgesia, S-ketamine, Pediatrics Trial in Guangzhou (S-ketamine & Ropivacaine, Ropivacaine)

Not yet recruiting
  • Postoperative Analgesia
  • +4 more
  • Guangzhou, Guangdong, China
    First Affiliated Hospital, Sun Yat-sen University
Jun 27, 2023

CHF, Heart Failure, Systolic, Heart Failure Trial in San Diego (SRD-001, Placebo)

Recruiting
  • Congestive Heart Failure
  • +2 more
  • SRD-001
  • Placebo
  • San Diego, California
    San Diego Cardiac Center
Jul 26, 2022

Insomnia Due to Anxiety and Fear Trial in Chengdu (DHM, Placebo)

Completed
  • Insomnia Due to Anxiety and Fear
  • DHM
  • Placebo
  • Chengdu, Sichuan, China
    Furise Group Co
Jan 3, 2023

FORCEREPAIR - A Wound Exudate Investigation

Not yet recruiting
  • Venous Leg Ulcer
  • +3 more
  • Standard of Care
  • Copenhagen, Northwest, Denmark
  • +1 more
Oct 26, 2023

Anorexia Nervosa, Anorexia Nervosa in Remission, Anorexia Nervosa Restricting Type Trial in Barcelona (Radically Open

Recruiting
  • Anorexia Nervosa
  • +2 more
  • Radically Open Dialectical Behaviour Therapy (RO-DBT)
  • +2 more
  • Barcelona, Spain
    Hospital de la Santa Creu i Sant Pau
Sep 15, 2023

Mild Cognitive Impairment, Alzheimer Dementia Trial (CpG1018, Placebo)

Not yet recruiting
  • Mild Cognitive Impairment
  • Alzheimer Dementia
  • (no location specified)
Jan 3, 2023

Primary Brain Tumor Trial in Houston (Hyperpolarized Carbon C 13 Pyruvate, Magnetic Resonance Spectroscopic Imaging)

Recruiting
  • Primary Brain Neoplasm
  • Hyperpolarized Carbon C 13 Pyruvate
  • Magnetic Resonance Spectroscopic Imaging
  • Houston, Texas
    M D Anderson Cancer Center
Nov 16, 2022

Multiple Myeloma in Relapse, Multiple Myeloma, Refractory Trial in Poitiers (Isatuximab, Carfilzomib, Pomalidomide)

Active, not recruiting
  • Multiple Myeloma in Relapse
  • Multiple Myeloma, Refractory
  • Poitiers, France
    CHU Poitiers
Jan 9, 2023

Migraine Trial in Leuven (UB-313, Placebo)

Recruiting
  • Migraine
  • UB-313
  • Placebo
  • Leuven, Belgium
    Katholieke Universiteit Leuven
Jul 25, 2022

Prostate Adenocarcinoma, PSA Level Greater Than Ten, Stage IIB Prostate Cancer AJCC v8 Trial in Houston (Hyperpolarized Carbon C

Active, not recruiting
  • Prostate Adenocarcinoma
  • +9 more
  • Hyperpolarized Carbon C 13 Pyruvate
  • Magnetic Resonance Spectroscopic Imaging
  • Houston, Texas
    M D Anderson Cancer Center
Nov 16, 2022